Journal article · 2026 · Open access

Mathematical and regulatory limitations of the similarity factor f2 under incomplete dissolution: analysis of the ICH M13B guideline and applicability of alternative metrics

Igor E. Shohin

Drug development & registration · Published 17 October 2026 · DOI 10.33380/2305-2066-2026-15-4-2477

Free PDFView at the publisherCite this paper

In brief

“Mathematical and regulatory limitations of the similarity factor f2 under incomplete dissolution: analysis of the ICH M13B guideline and applicability of alternative metrics” is a 2026 journal article by Igor E. Shohin, published in Drug development & registration. OpenAlex counts 0 citations as of 15 November 2026. It is open access under a CC BY licence: the full text is free to read at Drug development & registration.

Citations
0
References
8
Authors
1

Abstract

Introduction. The similarity factor f 2 (Moore & Flanner, 1996) remains the gold standard for assessing dissolution profile equivalence in pharmaceutical development, biowaiver procedures, and the justification of post-approval changes. However, the mathematical framework of this metric was conceived in the late 1990s strictly for routine quality control under complete dissolution conditions ( Q > 85 %). The international guideline ICH M13B establishes a threshold rule: dissolution profiles with less than 10 % release are deemed comparable without mathematical evaluation, whereas profiles exceeding 10 % release require calculation of f 2 (or Bootstrap f 2 ). Under non-sink conditions, typical for Biopharmaceutics Classification System (BCS) Class II and IV active substances in physiological media lacking surfactants, the f 2 metric loses sensitivity to relative kinetic discrepancies. Aim. To analyze the mathematical limitations of the similarity factor f 2 under incomplete dissolution, to perform a comparative evaluation of f 2 , the difference factor f 1 , and the Two One-Sided Tests (TOST) procedure, and to provide recommendations for statistical evaluation of comparative in vitro dissolution test (CIDT) data within the framework of EAEU regulations and the ICH M13B guideline. Materials and methods. Using a critical model CIDT scenario for a poorly soluble compound with mean dissolution profiles of the test product T = (6,0 %; 10,0 %; 13,0 %; 18,0 %); and the reference product R = (11.0 %;18.0 %; 22.0 %; 30.0 %); parallel calculations of f 2 and f 1 were performed in accordance with Annex 5 to the EEC Council Decision No. 85 dated November 3, 2016, along with an equivalence assessment on a relative logarithmic scale (TOST approach). Results and discussion. For the analyzed dataset, the f 2 metric was 52.49, formally satisfying the similarity criterion (f 2 ≥ 50), despite the reference product releasing 1.7—1.9 times faster and more completely than the test product. Conversely, calculation of the difference factor f 1 yielded 41.98 %, which is nearly three times higher than the regulatory threshold for acceptable difference (f 1 ≤ 15 %). The mean dissolution ratio T / R ranged between 54.55 % and 60.00 %, falling well outside the bioequivalence acceptance interval (80.00—125.00 %). This paradox arises from the absolute dimensionality of the Moore and Flanner metric, which is anchored to a 0—100 % scale and remains indifferent to substantial relative discrepancies at low analyte concentrations. Conclusion. Relying on f 2 within the range of incomplete dissolution (from 10 % to 30—40 %) introduces substantial regulatory and technical risks of concluding pseudo-equivalence between…

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Shohin, I. E. (2026). Mathematical and regulatory limitations of the similarity factor f2 under incomplete dissolution: analysis of the ICH M13B guideline and applicability of alternative metrics. Drug development & registration. https://doi.org/10.33380/2305-2066-2026-15-4-2477

MLA 9

Shohin, Igor E. “Mathematical and regulatory limitations of the similarity factor f2 under incomplete dissolution: analysis of the ICH M13B guideline and applicability of alternative metrics.” Drug development & registration, 2026. https://doi.org/10.33380/2305-2066-2026-15-4-2477.

Chicago

Shohin, Igor E. 2026. “Mathematical and regulatory limitations of the similarity factor f2 under incomplete dissolution: analysis of the ICH M13B guideline and applicability of alternative metrics.” Drug development & registration. https://doi.org/10.33380/2305-2066-2026-15-4-2477.

Harvard

Shohin, I. E. (2026) ‘Mathematical and regulatory limitations of the similarity factor f2 under incomplete dissolution: analysis of the ICH M13B guideline and applicability of alternative metrics’, Drug development & registration. doi:10.33380/2305-2066-2026-15-4-2477.

IEEE

I. E. Shohin, “Mathematical and regulatory limitations of the similarity factor f2 under incomplete dissolution: analysis of the ICH M13B guideline and applicability of alternative metrics,” Drug development & registration, 2026, doi: 10.33380/2305-2066-2026-15-4-2477.

BibTeX

@article{shohin2026mathematical,
  title     = {{Mathematical and regulatory limitations of the similarity factor f2 under incomplete dissolution: analysis of the ICH M13B guideline and applicability of alternative metrics}},
  author    = {Shohin, Igor E.},
  journal   = {Drug development \& registration},
  year      = {2026},
  doi       = {10.33380/2305-2066-2026-15-4-2477},
  url       = {https://doi.org/10.33380/2305-2066-2026-15-4-2477}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems

  • similarity factor f2
  • BCS class II
  • poorly water-soluble drugs
  • post-approval changes
  • biowaiver
  • quality by design

Work with this paper

Most-cited papers in Pharmacology, Toxicology and Pharmaceutics

All highly cited Pharmacology, Toxicology and Pharmaceutics papers

Questions about this paper

How do I cite this paper in APA style?

Shohin, I. E. (2026). Mathematical and regulatory limitations of the similarity factor f2 under incomplete dissolution: analysis of the ICH M13B guideline and applicability of alternative metrics. Drug development & registration. https://doi.org/10.33380/2305-2066-2026-15-4-2477

How many times has this paper been cited?

0 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access: read the free full text at Drug development & registration.

Who wrote this paper?

Igor E. Shohin.

What is the DOI of this paper?

10.33380/2305-2066-2026-15-4-2477. The permanent link is https://doi.org/10.33380/2305-2066-2026-15-4-2477.

Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.